COVID-19: A History

IF 0.5 Q3 AREA STUDIES

American Review of Canadian Studies Pub Date : 2022-10-02 DOI:10.1080/02722011.2022.2154309

P. Twohig

引用次数: 3

Abstract

Duffin estimates that 55 vaccines were in development and some, such as the mRNA vaccines developed by Pfizer-BioNTech and Moderna, were entirely novel. These are minor quibbles since Duffin works to her strengths as an historian and maintains a clear focus on the science, medicine, and public health responses to COVID-19. Duffin then turns to the science and medicine of COVID, including topics like testing, treatments, and the development of vaccines. [Extracted from the article]

查看原文本刊更多论文

COVID-19:一段历史

Duffin估计，有55种疫苗正在开发中，其中一些疫苗，如辉瑞生物技术公司和莫德纳公司开发的信使核糖核酸疫苗，是全新的。这些都是小的争论，因为Duffin发挥了她作为历史学家的优势，并明确关注科学、医学和公共卫生应对新冠肺炎。Duffin随后转向新冠肺炎的科学和医学，包括检测、治疗和疫苗开发等主题。[摘自文章]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Review of Canadian Studies AREA STUDIES-

CiteScore

0.60

自引率

0.00%

发文量

期刊介绍： American Nineteenth Century History is a peer-reviewed, transatlantic journal devoted to the history of the United States during the long nineteenth century. It welcomes contributions on themes and topics relating to America in this period: slavery, race and ethnicity, the Civil War and Reconstruction, military history, American nationalism, urban history, immigration and ethnicity, western history, the history of women, gender studies, African Americans and Native Americans, cultural studies and comparative pieces. In addition to articles based on original research, historiographical pieces, reassessments of historical controversies, and reappraisals of prominent events or individuals are welcome. Special issues devoted to a particular theme or topic will also be considered.